These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 32685027)

  • 1. Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy.
    Zhan Q; Yi K; Qi H; Li S; Li X; Wang Q; Wang Y; Liu C; Qiu M; Yuan X; Zhao J; Hou X; Kang C
    Theranostics; 2020; 10(17):7889-7905. PubMed ID: 32685027
    [No Abstract]   [Full Text] [Related]  

  • 2. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.
    Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z
    J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy.
    Yang L; Han D; Zhan Q; Li X; Shan P; Hu Y; Ding H; Wang Y; Zhang L; Zhang Y; Xue S; Zhao J; Hou X; Wang Y; Li P; Yuan X; Qi H
    Theranostics; 2019; 9(25):7680-7696. PubMed ID: 31695794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
    Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
    Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy.
    Gong C; Tian J; Wang Z; Gao Y; Wu X; Ding X; Qiang L; Li G; Han Z; Yuan Y; Gao S
    J Nanobiotechnology; 2019 Sep; 17(1):93. PubMed ID: 31481080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer.
    Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designer exosomes enabling tumor targeted efficient chemo/gene/photothermal therapy.
    Wang J; Chen P; Dong Y; Xie H; Wang Y; Soto F; Ma P; Feng X; Du W; Liu BF
    Biomaterials; 2021 Sep; 276():121056. PubMed ID: 34364178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.
    Tian Y; Li S; Song J; Ji T; Zhu M; Anderson GJ; Wei J; Nie G
    Biomaterials; 2014 Feb; 35(7):2383-90. PubMed ID: 24345736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer.
    Li Y; Gao Y; Gong C; Wang Z; Xia Q; Gu F; Hu C; Zhang L; Guo H; Gao S
    Nanomedicine; 2018 Oct; 14(7):1973-1985. PubMed ID: 29935333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging.
    Xie X; Chen Y; Chen Z; Feng Y; Wang J; Li T; Li S; Qin X; Wu C; Zheng C; Zhu J; You F; Liu Y; Yang H
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43865-43878. PubMed ID: 31684723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-mimetic nanoplatforms for targeted cancer drug delivery.
    Vázquez-Ríos AJ; Molina-Crespo Á; Bouzo BL; López-López R; Moreno-Bueno G; de la Fuente M
    J Nanobiotechnology; 2019 Jul; 17(1):85. PubMed ID: 31319859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
    Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Exosomes Reprogrammed by Low pH Are Efficient Targeting Vehicles for Smart Drug Delivery and Personalized Therapy against their Homologous Tumor.
    Gong C; Zhang X; Shi M; Li F; Wang S; Wang Y; Wang Y; Wei W; Ma G
    Adv Sci (Weinh); 2021 May; 8(10):2002787. PubMed ID: 34026432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy.
    Qi H; Liu C; Long L; Ren Y; Zhang S; Chang X; Qian X; Jia H; Zhao J; Sun J; Hou X; Yuan X; Kang C
    ACS Nano; 2016 Mar; 10(3):3323-33. PubMed ID: 26938862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-antitumor therapy and synchronous imaging monitoring based on exosome.
    Qian R; Jing B; Jiang D; Gai Y; Zhu Z; Huang X; Gao Y; Lan X; An R
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2668-2681. PubMed ID: 35091755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system.
    Jing P; Cao S; Xiao S; Zhang X; Ke S; Ke F; Yu X; Wang L; Wang S; Luo Y; Zhong Z
    Cancer Lett; 2016 Dec; 383(2):230-242. PubMed ID: 27721020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome-based hybrid nanostructures for enhanced tumor targeting and hyperthermia therapy.
    Kwon SH; Faruque HA; Kee H; Kim E; Park S
    Colloids Surf B Biointerfaces; 2021 Sep; 205():111915. PubMed ID: 34130212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy.
    Yong T; Zhang X; Bie N; Zhang H; Zhang X; Li F; Hakeem A; Hu J; Gan L; Santos HA; Yang X
    Nat Commun; 2019 Aug; 10(1):3838. PubMed ID: 31444335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROS triggered local delivery of stealth exosomes to tumors for enhanced chemo/photodynamic therapy.
    Wan Z; Gan X; Mei R; Du J; Fan W; Wei M; Yang G; Qin W; Zhu Z; Liu L
    J Nanobiotechnology; 2022 Aug; 20(1):385. PubMed ID: 35999549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.